meta_pixel
Tapesearch Logo
Log in
Industry Focus

Healthcare: Top MedTech Stocks in Diabetes

Industry Focus

The Motley Fool

Interview, Money, Consumergoods, Business, Businessnews, Ceo, Technology, Investing, Stocks, Energy, Fool, Financial, Economy, Healthcare, News, Banking, Motley, Tech, Business News, Investments

4.6854 Ratings

🗓️ 23 May 2018

⏱️ 25 minutes

🧾️ Download transcript

Summary

It’s not just drugmakers disrupting this massive market, medical device makers are pocketing billions of dollars, too. Here’s what you should know about Medtronic, Abbott Labs, Dexcom, Insulet, and Tandem Diabetes. (NYSE: MDT)(NYSE: ABT)(NASDAQ: DXCM) NASDAQ: PODD)(NASDAQ: TNDM).

Transcript

Click on a timestamp to play from that location

0:00.0

Welcome to Industry Focus, the podcast that dives into a different sector of the stock market every day.

0:07.0

We're talking health care today, May 23rd.

0:10.0

I'm your host, Christine Harjus.

0:11.0

Calling in full HQ in Alexandria, Virginia

0:14.1

is Fool.com, health care contributor,

0:16.2

Todd, what's the latest?

0:19.1

I'm excited.

0:19.8

I'm excited to talk today about what I think

0:22.2

could be one of the most important investing

0:24.9

themes in health care over the course of the next 10 to 20 years.

0:28.6

Absolutely. So today just to dive right in we're talking about the diabetes space and specifically some medical

0:34.9

device makers within the diabetes space.

0:38.6

We got a listener email from Brian B.

0:40.8

Thanks for writing in, who noticed that we tend to cover a lot of

0:44.9

pharma companies and drug makers and it's true we do. They have a lot of growth

0:48.6

potential. I think they're very exciting. They have clinical updates all the time.

0:52.0

But Brian suggested that we spend a little bit more time of our coverage talking about medical devices and they're makers.

1:00.0

So today we thought we would do just that specifically regarding the diabetes market.

1:05.1

I mean the impact of this disease as you already alluded to Todd is staggering and the number of

1:10.4

patients is growing very quickly.

1:12.9

So can you kick us off with some more background?

1:14.8

Sure, I think it might be helpful to begin with what is diabetes, right?

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.